TAHA ÖZER, Özgür BAŞLARLI, ALPER AKTAŞ, EMRE BARIŞ, HAKAN HAMDİ ÇELİK, Mert OCAK

Locally administrated single-dose teriparatide affects critical-size rabbit calvarial defects: A histological, histomorphometric and micro-CT study

Objective: The aim of this study was to evaluate the effect of teriparatide (PTH 1-34, rhPTH) on a rabbit defect model with local xenogen grafts histomorphometrically and radiologically. Methods: For this purpose, two 10 mm diameter critical-size defects were created in the calvaria of 16 rabbits. In the control group, the defect area was filled with a xenogen graft, while in the teriparatide group (PTH 1-34), a xenogen graft combination with 20 mcg teriparatide was used. For both 4 e week and 8 e week study groups, new bone, residual graft, and soft tissue areas were evaluated as well as bone volume histomorphometrically and radiologically. Results: Histomorphometrically, there was a significant difference in new bone area values at the 8th week (p < 0.05), but there was no significant difference between the 4 e week values (p > 0.05). There was no statistically significant difference between the groups at both 4 and 8 weeks (p > 0.05). In the radiologically measured total bone volume values, PTH1-34 group values were found to be significantly higher for both 4 e and 8 e weeks values compared to the control groups (p < 0.05). Conclusion: In this study, rhPTH, which is used locally in defect areas to be repaired with bone grafts, increases both new bone volume and total bone volume.

___

1. Giannoudis P, Psarakis S, Kontakis G. Can we accelerate fracture healing? A critical analysis of the literature. Injury. 2007;38(1):S81eS89.

2. Bezerra BT, Pinho JNA, Figueiredo FED, Brandao J, Ayres LCG, da Silva LCF. Autogenous bone graft versus bovine bone graft in association with plateletrich plasma for the reconstruction of alveolar clefts: a pilot study. Cleft Palate Craniofac J. 2019;56(1):134e140.

3. Aggarwal P, Zavras A. Parathyroid hormone and its effects on dental tissues. Oral Dis. 2012;18(1):48e54.

4. Li YF, Li XD, Bao CY, Chen QM, Zhang H, Hu J. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface. Osteoporos Int. 2013;24(3): 1063e1071.

5. Tokunaga K, Seto H, Ohba H, et al. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis. J Periodontal Res. 2011;46(6):655e662.

6. Cosman F. Parathyroid hormone treatment for osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2008;15(6):495e501.

7. Skripitz R, Aspenberg P. Parathyroid hormoneea drug for orthopedic surgery? Acta Orthop Scand. 2004;75(6):654e662.

8. Auersvald CM, Santos FR, Nakano MM. The local administration of parathyroid hormone encourages the healing of bone defects in the rat calvaria: microcomputed tomography, histological and histomorphometric evaluation. Arch Oral Biol. 2017;79(1):14e19.

9. Marx J. Coming to grips with bone loss. Science. 2004;305(5689):1420e1422.

10. Deal C, Gideon J. Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis. Cleve Clin J Med. 2003;70(7):585e586, 589e590, 592e4 passim.

11. Ghiasi MS, Chen J, Vaziri A, Rodriguez EK, Nazarian A. Bone fracture healing in mechanobiological modeling: a review of principles and methods. Bone Rep. 2017;6(1):87e100.

12. Pripatnanont P, Nuntanaranont T, Vongvatcharanon S. Proportion of deproteinized bovine bone and autogenous bone affects bone formation in the treatment of calvarial defects in rabbits. Int J Oral Maxillofac Surg. 2009;38(4): 356e362.

13. Pripatnanont P, Nuntanaranont T, Vongvatcharanon S, Phurisat K. The primacy of platelet-rich fibrin on bone regeneration of various grafts in rabbit's calvarial defects. J Craniomaxillofac Surg. 2013;41(8):e191ee200.

14. Tsunori K. Effects of parathyroid hormone dosage and schedule on bone regeneration. J Oral Sci. 2015;57(2):131e136.

15. Tsunori K, Sato S, Hasuike A, et al. Effects of intermittent administration of parathyroid hormone on bone augmentation in rat calvarium. Implant Dent. 2015;24(2):142e148.

16. Skripitz R, Johansson HR, Ulrich SD, Werner A, Aspenberg P. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats. J Orthop Sci. 2009;14(2):138e143.

17. Kuroshima S, Al-Salihi Z, Yamashita J. Parathyroid hormone related to bone regeneration in grafted and nongrafted tooth extraction sockets in rats. Implant Dent. 2013;22(1):71e76.

18. Ohata T, Maruno H, Ichimura S. Changes over time in callus formation caused by intermittently administering PTH in rabbit distraction osteogenesis models. J Orthop Surg Res. 2015;10(1):88e95.

19. Aleksyniene R, Thomsen JS, Eckardt H, Bundgaard KG, Lind M, Hvid I. Threedimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening model. J Musculoskelet Neuronal Interact. 2009;9(4):268e277.

20. Sohn JY, Park JC, Um YJ, et al. Spontaneous healing capacity of rabbit cranial defects of various sizes. J Periodontal Implant Sci. 2010;40(4):180e187.

21. Jensen T, Schou S, Svendsen PA, et al. Volumetric changes of the graft after maxillary sinus floor augmentation with Bio-Oss and autogenous bone in different ratios: a radiographic study in minipigs. Clin Oral Implant Res. 2012;23(8):902e910.

22. Orsini G, Scarano A, Degidi M, Caputi S, Iezzi G, Piattelli A. Histological and ultrastructural evaluation of bone around Bio-Oss particles in sinus augmentation. Oral Dis. 2007;13(6):586e593.

23. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003;18(11):1932e1941.

24. Dempster DW, Cosman F, Kurland ES, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res. 2001;16(10):1846e1853.

25. Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1-34) therapy in women with severe osteoporosis. Bone. 2000;27(2):311e318.

26. Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone. 2008;42(1):90e97.

27. Nakajima A, Shimoji N, Shiomi K, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res. 2002;17(11):2038e2047.

28. Andreassen TT, Fledelius C, Ejersted C, Oxlund H. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand. 2001;72(3):304e307.

29. Lehman Jr RA, Dmitriev AE, Cardoso MJ, et al. Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model. Spine (Phila Pa 1976). 2010;35(2):146e152.

30. Tao ZS, Zhou WS, Wu XJ, et al. Single-dose local administration of parathyroid hormone (1-34, PTH) with beta-tricalcium phosphate/collagen (beta-TCP/COL) enhances bone defect healing in ovariectomized rats. J Bone Miner Metab. 2019;37(1):28e35.

31. Himeno-Ando A, Izumi Y, Yamaguchi A, Iimura T. Structural differences in the osteocyte network between the calvaria and long bone revealed by threedimensional fluorescence morphometry, possibly reflecting distinct mechanoadaptations and sensitivities. Biochem Biophys Res Commun. 2012;417(2):765e770.

32. Deluiz D, Oliveira LS, Pires FR, Tinoco EM. Time-dependent changes in freshfrozen bone block grafts: tomographic, histologic, and histomorphometric findings. Clin Implant Dent Relat Res. 2015;17(2):296e306.